Related Experiment Video
Updated: Jun 13, 2026

Characterizing Mammalian Zinc Transporters Using an In Vitro Zinc Transport Assay
Published on: June 2, 2023
The zinc contraceptive effect: targets, timing, and quantitative thresholds
Kirsten Shankie-Williams1, Margot Day1, Samson Dowland1
1School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia.
Abstract:
There is a critical need for novel non-hormonal contraceptives. Zinc-based intrauterine devices (IUDs) demonstrate 100% efficacy in rats, yet the mechanism remains unclear. We investigated whether zinc targets sperm, embryos, or the endometrium. Rats with zinc, copper, or nylon IUDs were mated. All retrieved embryos were fertilised, indicating no primary spermicidal effect. However, embryos from rats with a zinc IUD failed to reach the blastocyst stage, unlike those from rats with a copper IUD. In vitro embryo culture confirmed that zinc significantly inhibited mouse embryo development in a dose-dependent manner, with 5 μg/ml zinc causing a 97% decrease in blastocyst formation, whilst copper caused a 61% decrease. Surviving zinc-treated embryos also had significantly reduced attachment to human endometrial cells, unlike copper-treated embryos. There was also no reduced attachment of untreated mouse embryos to zinc- and copper-treated endometrial cells. These findings suggest that zinc's primary contraceptive mechanism is the potent inhibition of pre-implantation embryo development.
Related Concept Videos
Birth Control Methods
Intrauterine Drug Delivery Systems
Drug Concentration Versus Time Correlation
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the lowest drug...
Feedback Regulation of Calcium Concentration
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
Pharmacodynamic Models: Linear Concentration–Effect Model
Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship
